Valuation: RushNet, Inc.

Market Cap 12.26M 10.89M 10.16M 9.26M 17.48M 1.18B 17.64M 123M 47.72M 602M 46.04M 45.04M 1.94B P/E 2020
13.3x
P/E 2021 55x
Enterprise Value 18.19M 16.16M 15.07M 13.74M 25.93M 1.75B 26.16M 183M 70.79M 893M 68.3M 66.82M 2.87B EV / Sales 2020
2.75x
EV / Sales 2021 1.77x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week 0
Extreme 1.0E-6
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0.02
Manager TitleAgeSince
Chief Executive Officer - 03/03/2024
Chief Operating Officer 45 01/08/2021
Director TitleAgeSince
Chairman - 03/03/2024
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 8.77K
+0.23%-1.83%+3.09%+57.62% 662B
-1.32%-3.45%-4.73%+60.56% 77.11B
+4.54%+3.25%+10.22%+153.79% 67.29B
+4.53%+2.31%+89.72%+1,182.00% 66.55B
-0.49%-4.07%-23.75%-7.85% 45.17B
+0.39%-2.73%-3.40%+77.40% 44.93B
+1.97%+2.72%+13.11%+32.34% 31.59B
+1.25%-0.88%+36.86%+57.99% 25.91B
-2.25%-4.56%-65.22%-60.05% 23.59B
Average +0.88%-0.48%+6.21%+172.64% 104.42B
Weighted average by Cap. +0.67%-1.28%+6.65%+130.31%

Financials

2020 2021
Net sales 4.39M 3.9M 3.63M 3.31M 6.25M 423M 6.31M 44.02M 17.07M 215M 16.47M 16.11M 692M 5.9M 5.24M 4.88M 4.45M 8.4M 568M 8.48M 59.16M 22.94M 289M 22.14M 21.66M 930M
Net income 991K 880K 820K 748K 1.41M 95.41M 1.42M 9.94M 3.85M 48.62M 3.72M 3.64M 156M 164K 145K 135K 123K 233K 15.75M 235K 1.64M 636K 8.03M 614K 601K 25.81M
Net Debt 5.87M 5.21M 4.86M 4.43M 8.37M 565M 8.44M 58.89M 22.84M 288M 22.04M 21.56M 926M 5.93M 5.27M 4.91M 4.48M 8.45M 571M 8.53M 59.48M 23.07M 291M 22.26M 21.77M 936M
Logo RushNet, Inc.
RushNet, Inc. provides management and insurance billing services to clinical laboratories and laboratory services. The Company’s subsidiaries include Chattahoochee Physicians Laboratory Services, LLC, doing business as HeliosDx, and Grandeza Healthcare Consultants, LLC (Grandeza). HeliosDx offers urine drug testing, allergy droplet cards, oral fluids, Polymerase Chain Reaction (PCR) for nails, wounds, respiratory pathogens, sexually transmitted infections, gastrointestinal issues, urinary tract infections, and pharmacogenomics testing through lab partners. Grandeza provides management and insurance billing services to clinical reference laboratories.
Employees
18
Date Price Change Volume
02/10/26 US$0.000001 0.00% 2,000,001
01/10/26 US$0.000001 0.00% 1,600,500
29/09/26 US$0.000001 0.00% 20,000
28/09/26 US$0.000001 0.00% 20,000
  1. Stock Market
  2. Stocks
  3. RSHN Stock